PSNL:NASDAQ, Personalis, Inc.
PSNL stock overview
Personalis, Inc. (PSNL:NASDAQ) closed at $15.82 on October 22, 2026,
down 0.50% on the day.
The stock trades 16.3% below its 52-week high of $18.89
and 219.3% above its 52-week low of $4.96.
Over the past year, it gained 78.2%.
Personalis, Inc. is part of the Health Care sector (Medical Specialities).
Key figures
- Price
- $15.82
- Day change
- -0.50%
- Volume
- 2,694,754
- Average volume
- 2,893,368
- Market cap
- 1B+
- 52-week range
- $4.96 – $18.89
- 50-day average
- $16.18
- 200-day average
- $11.04
Price action over the past year
In 252 trading sessions since October 22, 2025, PSNL closed higher on 127 days (50%).
Its best day was November 10, 2025 (+24.53%) and its worst was March 12, 2026 (-17.11%).
The stock moved 10% or more in a single session 19 times.
It opened at least 5% above the previous day's high 4 times.
Recent signals
PSNL news
-
Oct 22, 2026:
Are VRNS, DSGR, PSNL Obtaining Fair Deals for their Shareholders?
-
Oct 21, 2026:
Personalis NeXT Personal Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
-
Oct 21, 2026:
Personalis NeXT Personal® Data Showcasing Ultrasensitive MRD to be Presented at ESMO 2026
-
Oct 20, 2026:
Personalis Brings Resistance Mutation Tracking to NeXT Personal® MRD Test
-
Oct 20, 2026:
Personalis Brings Resistance Mutation Tracking to NeXT Personal MRD Test
-
Oct 20, 2026:
Personalis (PSNL) Stock Looks Richly Valued As Shares Surge 14x In 3 Years
-
Sep 22, 2026:
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
-
Sep 17, 2026:
Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak
About Personalis, Inc.
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies.
Similar stocks
Find more stocks like PSNL with the
Spikes,
Gaps,
Breakouts and
Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.